PMID: 6404750Mar 1, 1983Paper

Myasthenia gravis: mechanisms and management

Hospital Practice
R P Lisak

Abstract

Myasthenia gravis is an autoimmune disease of known cause: an antibody to a specific molecule of defined structure. As long as the abnormality leading to the antibody response remains elusive, however, so will ideal treatment. In the meantime, most patients given proper management can lead normal or near-normal lives; prognosis is surprisingly good, and mortality should approach zero.

References

May 18, 1978·The New England Journal of Medicine·D B DrachmanG J Hoffman
Sep 1, 1982·Annals of Neurology·J J KellyB R Younge

❮ Previous
Next ❯

Citations

May 1, 1987·Journal of Clinical Immunology·A I LevinsonR P Lisak
Oct 1, 1991·DICP : the Annals of Pharmacotherapy·P A Keys, R P Blume
Dec 1, 1991·Arquivos de neuro-psiquiatria·L C Werneck, P R Moreira
Dec 1, 1987·Arquivos de neuro-psiquiatria·L C Werneck, H A Teive

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

JAMA : the Journal of the American Medical Association
Raffaele Bugiardini, C Noel Bairey Merz
The American Journal of Sports Medicine
Davide BlonnaShawn W O'Driscoll
© 2021 Meta ULC. All rights reserved